STINGVAX, a cancer vaccine comprising CDNs (activating TBK1/IRF3, NF-κB, and STAT6 signaling pathways) and GM-CSF, has shown promising results in different murine tumor models (Table 1). Here, NFKB1 is linked to neoplasm.